Belite Bio announces promising phase 3 results for Stargardt disease
The latest research news from Retina UK.
Search results
The latest research news from Retina UK.
Emily Kearney is mum to four boys, aged four to 13, two of whom are living with an inherited sight loss condition.
Ocugen’s gene therapy candidate, OCU410ST, is an experimental treatment designed to slow vision loss in Stargardt disease, an inherited retinal disease (IRD) with no approved therapies currently.
We sat down to discuss all about who Retina UK are.
Inside: Our intrepid Sahara Trek #TeamRetinaUK tell us about their incredible experience. 2026 is now fully underway and we are excited to tell you about our plans. Could you take part in a challenge event or volunteer to do a bucket collection in London for Retina UK?
Our young adults got to grips with white water rafting recently, building confidence and resilience while having fun.
The Spring 2023 edition of the Retina UK newsletter, Look Forward, which includes articles about our upcoming events, research updates and more.
Your doctor or genetic counsellor will spend some time asking about other people in your family to try to work out the way in which your particular faulty gene has been passed down through the generations – this is referred to as the inheritance pattern.
If stunning views, inspiring history and graffiti murals are your thing, then this is the race for you in 2026. With a flat course and thousands of runners taking to the streets, it's a fantastic event to be a part of.